Utilisation of galacto-oligosaccharides as selective substrates for growth by lactic acid bacteria including Bifidobacterium lactis DR10 and Lactobacillus rhamnosus DR20

被引:132
作者
Gopal, PK
Sullivan, PA
Smart, JB
机构
[1] New Zealand Dairy Res Inst, Palmerston North, New Zealand
[2] Massey Univ, Inst Mol Biosci, Palmerston North, New Zealand
关键词
galacto-oligosaccharides; probiotics; prebiotics; Lb. rhamnosus DR20; B. lactis DR10;
D O I
10.1016/S0958-6946(01)00026-7
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Two probiotic strains of bacteria Bifidobacterium lactis DR10 and Lactobacillus rhamnosus DR20 were tested for their ability to utilise and grow on galacto-oligosaccharides present in a commercial hydrolysed lactose milk powder. The results clearly demonstrated that B. lactis DR10 preferentially utilises tri- and tetra-saccharides whereas Lb. rhamnosus DR20 prefers sugars with a lower degree of polymerisation, i.e., disaccharides and monosaccharides. Since galacto-oligosaccharides are non-digestible oligosaccharides, this in vitro data suggest that galacto-oligosaccharides present in milk powders are likely to promote growth of DR10 and DR20 in vivo if these strains are consumed in combination with the milk powder. Fifty four strains of lactic acid bacteria, including members from the genera Bifidobacterium and Lactobacillus, were studied for their ability to utilise lactose derived oligosaccharides. A perfect correlation was observed between the ability of a strain to utilise oligosaccharide and the presence of the lactose hydrolysing enzyme beta -galactosidase. Based on these observations, a mechanism for the utilisation of galacto-oligosaccharides in genus bifidobacteria is proposed that may help to explain the ability of these organisms to out-compete other bacteria in the ecosystcm of the human gastro-intestinal tract. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:19 / 25
页数:7
相关论文
共 27 条
[1]   Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019) [J].
Arunachalam, K ;
Gill, HS ;
Chandra, RK .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2000, 54 (03) :263-267
[2]   Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans [J].
Bouhnik, Y ;
Flourie, B ;
DAgayAbensour, L ;
Pochart, P ;
Gramet, G ;
Durand, M ;
Rambaud, JC .
JOURNAL OF NUTRITION, 1997, 127 (03) :444-448
[3]   MOLECULAR-CLONING OF LACTOSE GENES IN DIARY LACTIC STREPTOCOCCI - THE PHOSPHO-BETA-GALACTOSIDASE AND BETA-GALACTOSIDASE GENES AND THEIR EXPRESSION PRODUCTS [J].
DEVOS, WM ;
SIMONS, G .
BIOCHIMIE, 1988, 70 (04) :461-473
[4]   COLORIMETRIC METHOD FOR DETERMINATION OF SUGARS AND RELATED SUBSTANCES [J].
DUBOIS, M ;
GILLES, KA ;
HAMILTON, JK ;
REBERS, PA ;
SMITH, F .
ANALYTICAL CHEMISTRY, 1956, 28 (03) :350-356
[5]   Dietary modulation of the human gut microflora using prebiotics [J].
Gibson, GR .
BRITISH JOURNAL OF NUTRITION, 1998, 80 (04) :S209-S212
[6]   Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) [J].
Gill, HS ;
Rutherfurd, KJ ;
Prasad, J ;
Gopal, PK .
BRITISH JOURNAL OF NUTRITION, 2000, 83 (02) :167-176
[7]  
GYORGY P, 1973, SUGARS NUTR, P101
[8]  
Ishikawa F, 1995, BIFIDUS, V9, P5
[9]  
ITO M, 1990, Microbial Ecology in Health and Disease, V3, P285
[10]  
JACKSON P, 1994, METHOD ENZYMOL, V230, P250